Roivant Sciences (ROIV) Non Operating Investment Income (2020 - 2026)
Roivant Sciences (ROIV) recorded Non Operating Investment Income of $36.64 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$19.13 million a year earlier.
Powered by 
Analysis
Roivant Sciences (ROIV) Non Operating Investment Income (2020 - 2026) Analysis & Trends
On a TTM basis, Roivant Sciences' Non Operating Investment Income came in at $160.81 million as of Jun 30, 2026, up 671.8% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $105.05 million, up 90.3% from FY2025.
- Annual Non Operating Investment Income has a five-year compound annual growth rate of 1.9% (FY2021 to FY2026).
- Across earlier fiscal years, Non Operating Investment Income came in at $55.19 million in FY2025, -$47.97 million in FY2024, $29.28 million in FY2023 (-93.4%) and $443.75 million in FY2022 (+364.5%).
- Quarterly Non Operating Investment Income has ranged from -$54.68 million in fiscal Q2 2023 to $443.75 million in fiscal Q2 2022 over the past five years.
- Per Business Quant, the preceding three fiscal quarters came in at -$25.92 million (Q4 2026), $21.59 million (Q3 2026) and $128.5 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Op. Investment Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Roivant Sciences | 25.81 Bn | 26.50 Bn | 1.16 Mn | 36.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 36.64 Mn |
| Mar 31, 2026 | -25.92 Mn |
| Dec 31, 2025 | 21.59 Mn |
| Sep 30, 2025 | 128.50 Mn |
| Jun 30, 2025 | -19.13 Mn |
| Mar 31, 2025 | 12.90 Mn |
| Dec 31, 2024 | -21.31 Mn |
| Sep 30, 2024 | 48.38 Mn |
| Jun 30, 2024 | 15.23 Mn |
| Mar 31, 2024 | 15.91 Mn |
| Dec 31, 2023 | -10.47 Mn |
| Sep 30, 2023 | -45.85 Mn |
| Jun 30, 2023 | -7.56 Mn |
| Mar 31, 2023 | 82.55 Mn |
| Dec 31, 2022 | 25.95 Mn |
| Sep 30, 2022 | -54.68 Mn |
| Jun 30, 2022 | -24.55 Mn |
| Dec 31, 2021 | -38.04 Mn |
| Sep 30, 2021 | 443.75 Mn |
| Jun 30, 2021 | -8.62 Mn |
API Access
Roivant Sciences Non Operating Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=ROIV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-investment-income", "ticker": "ROIV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=ROIV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();